A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)

BACKGROUNDS: Preventing distant recurrence and achieving local control are important challenges in rectal cancer treatment, and use of adjuvant chemotherapy has been studied. However, no phase III study comparing adjuvant chemotherapy regimens for rectal cancer has demonstrated superiority of a spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, E., Murata, A., Yoshida, K., Maeda, K., Ikejiri, K., Munemoto, Y., Sasaki, K., Matsuda, C., Kotake, M., Suenaga, T., Matsuda, H., Emi, Y., Kakeji, Y., Baba, H., Hamada, C., Saji, S., Maehara, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922318/
https://www.ncbi.nlm.nih.gov/pubmed/27056996
http://dx.doi.org/10.1093/annonc/mdw162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922318/
https://www.ncbi.nlm.nih.gov/pubmed/27056996
http://dx.doi.org/10.1093/annonc/mdw162

Ejemplares similares